Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Revista De Neurologia|November 5, 2011
[Hospital processes and costs in neurology. A study of a referral hospital]Esther Canto-Torán, David Vivas-Consuelo, Isabel Barrachina-Martinez, et al.
Health and Quality of Life Outcomes|January 13, 2019
Measurement of health-related quality by multimorbidity groups in primary health careMagdalena Millá-Perseguer, Natividad Guadalajara-Olmeda, David Vivas-Consuelo, et al.
Revista Espanola De Salud Publica|September 20, 2012
[Incidence and variability of temporary disability due to anxiety disorders during 2009 in the Valencia Community, Spain]Joaquín Andani Cervera, Natividad Guadalajara Olmeda, Isabel Barrachina Martínez, et al.
Revista Espanola De Salud Publica|June 9, 2016
[Impact of Morbidity on Health Care Costs of a Department of Health through Clinical Risk Groups. Valencian Community, Spain]Vicent Caballer Tarazona, Natividad Guadalajara Olmeda, David Vivas Consuelo, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 24, 2015
Methods to control the pharmaceutical cost impact of chronic conditions in the elderlyDavid Vivas-Consuelo, Ruth Usó-Talamantes, José Luis Trillo-Mata, et al.
Diabetic Foot & Ankle|July 3, 2018
Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcersMartin Romero Prada, Carolina Roa, Pamela Alfonso, et al.
Revista Espanola De Salud Publica|April 25, 2018
[Direct hospitalization costs associated with chronic Hepatitis C in the Valencian Community in 2013]Isabel Barrachina Martínez, Remedios Giner Durán, David Vivas-Consuelo, et al.
BMC Health Services Research|August 19, 2016
Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record dataCarla Sancho-Mestre, David Vivas-Consuelo, Luis Alvis-Estrada, et al.
International Journal of Environmental Research and Public Health|January 20, 2021
COVID-19, Fake News, and Vaccines: Should Regulation Be Implemented?Julio Emilio Marco-Franco, Pedro Pita-Barros, David Vivas-Orts, et al.
Health Policy (Amsterdam, Netherlands)|February 11, 2014
Predictability of pharmaceutical spending in primary health services using Clinical Risk GroupsDavid Vivas-Consuelo, Ruth Usó-Talamantes, José Luis Trillo-Mata, et al.
Pageof 3